The DOT return-to-duty process applies after an employee violates a DOT drug or alcohol regulation. Until the required process is successfully completed, the employee cannot perform DOT-regulated safety-sensitive duties.
Under 49 CFR Part 40, Subpart O, employees who violate DOT drug and alcohol regulations must complete the applicable return-to-duty process before resuming safety-sensitive work.
A drug-test laboratory finding is not necessarily the final violation. For a DOT drug test, the Medical Review Officer (MRO) completes the required verification process before a qualifying positive result is reported as verified. A legitimate medical explanation, such as a valid prescription, can affect how the result is verified.
For FMCSA-regulated CDL drivers, a qualifying violation can also create a prohibited status in the Drug and Alcohol Clearinghouse. Completing the return-to-duty process can restore eligibility to perform safety-sensitive work, but it does not require an employer to reinstate or rehire the driver.

What Triggers the DOT Return-to-Duty Process?
The DOT return-to-duty process is required after certain drug and alcohol violations, including:
- A verified positive DOT drug test
- A DOT alcohol test with an alcohol concentration of 0.04 or greater
- A refusal to test
- Certain adulterated or substituted specimen violations
- Another qualifying violation of a DOT drug-and-alcohol regulation
The exact requirements depend on the type of violation and the DOT agency that regulates the employee.
For drug testing, the MRO completes the required verification process before a laboratory finding becomes a verified positive result.
If prescription medication may explain a drug-test finding, our guide to DOT drug tests with a prescription explains how the MRO review works.
Step 1: Removal from safety-sensitive duties
After the employer receives a verified positive result, verified refusal, or another qualifying violation, the employee must be removed from DOT safety-sensitive duties immediately.
For commercial drivers, that means they cannot operate a commercial motor vehicle. Under DOT’s employer-action rule, the employee cannot return to safety-sensitive work until the return-to-duty process is complete.
For FMCSA-regulated CDL drivers, a violation may also result in a prohibited Clearinghouse status.
Step 2: The employer provides SAP information
The employer must give the employee a list of qualified Substance Abuse Professionals, commonly called SAPs. The employee may select a SAP from that list or find another professional who meets DOT qualification requirements.
DOT’s SAP-information requirement applies to employees and applicants who violate DOT drug-and-alcohol rules.
Step 3: Initial SAP evaluation
The SAP conducts an initial evaluation and recommends education, treatment, or both.
The recommendation is based on the employee’s individual evaluation. There is no standard course or fixed number of sessions that applies to every driver.
Step 4: Complete education or treatment
The employee must complete the program recommended by the SAP before moving forward.
That may include education, treatment, counseling, or a combination of services. Enrolling in a program or attending one appointment does not complete this stage.
Step 5: SAP follow-up evaluation
After the employee completes the recommended program, they return to the SAP for a follow-up evaluation.
The SAP decides whether the employee successfully complied with the recommendations. If more treatment, education, or documentation is needed, the employee must complete those requirements before becoming eligible for a return-to-duty test.
Step 6: Negative return-to-duty test
The employer arranges the return-to-duty test after receiving the SAP’s follow-up evaluation.
For a drug violation, the return-to-duty urine collection is directly observed. The employee must receive a negative drug-test result before resuming safety-sensitive work. For an alcohol violation, the employee must have an alcohol result below 0.02.
Under DOT’s return-to-duty requirements, the employer decides whether to return the employee to work after those conditions are met.
For an FMCSA-regulated driver, the employer reports the negative return-to-duty test result to the Clearinghouse. The driver’s status can then change from prohibited to not prohibited.
Step 7: Unannounced follow-up testing
Returning to work does not end the process.
The SAP creates a written follow-up testing plan. It must include at least six unannounced follow-up tests during the first 12 months of safety-sensitive work. The SAP may require additional testing for up to 48 more months.
Follow-up drug collections are directly observed. The SAP determines whether the plan includes drug testing, alcohol testing, or both. DOT’s follow-up testing rule requires the employer to carry out the SAP’s plan exactly as written.
The follow-up testing obligation remains with the employee. If the employee changes DOT-regulated employers before the plan is complete, the new employer must continue the remaining requirements.
How long does the DOT return-to-duty process take?
There is no fixed timeline. The length depends on the SAP’s recommendations, the employee’s completion of education or treatment, and the timing of the required evaluations and testing.
Some employees complete the process in weeks. Others need months. The return-to-duty test cannot be scheduled until the SAP determines that the employee successfully complied with the recommendations.

Can a driver work in a non-safety-sensitive role during the process?
Possibly. DOT rules prohibit safety-sensitive work, not every type of employment.
Whether another role is available depends on the employer’s policy, the employee’s qualifications, and the duties involved. The employer should confirm that any alternative position is not safety-sensitive under the applicable DOT agency rules.
Who pays for SAP services and return-to-duty testing?
DOT regulations do not require the employer to pay for SAP services, education, treatment, or testing.
Payment depends on employer policy, a collective bargaining agreement, or another arrangement between the employer and employee.
What if the result was dilute, involved a prescription, or is disputed?
A negative dilute DOT drug-test result is not automatically a failed test and follows separate DOT procedures.
An employee who receives MRO notification of a verified positive result may request a DOT split-specimen test. The second laboratory tests the reserve portion of the original urine collection, not a new sample.
Frequently asked questions
Can I return to driving after a failed DOT drug test?
You must complete the SAP process and receive a negative return-to-duty test before resuming DOT safety-sensitive work. For FMCSA-regulated drivers, the employer must also report the negative return-to-duty test to the Clearinghouse.
Does the return-to-duty process erase a DOT violation?
No. For FMCSA-regulated CDL drivers, a violation record remains in the Clearinghouse for five years from the violation determination date, or until the return-to-duty process and follow-up testing plan are complete, whichever is later.
Can I change trucking companies during follow-up testing?
Yes, but changing employers does not end the follow-up testing plan. The new DOT-regulated employer must ensure the remaining SAP-required tests are completed.
Can an employer add extra follow-up tests?
No. The employer must follow the SAP’s testing plan and cannot add DOT follow-up testing requirements beyond it.
Employers that need help coordinating DOT testing, MRO review, SAP documentation, and follow-up testing can contact New Era Drug Testing.
This article provides general information about DOT return-to-duty procedures. It is not legal or medical advice. New Era Drug Testing is an independent compliance services provider and is not affiliated with DOT, FMCSA, or any federal agency.